Luminex Webinars

For a startup company striving to deliver diagnostics that improve health care for patients who may have prostate cancer, Luminex’s xMAP® Technology is a critical tool in the assay development process. According to a webinar pr...

During the presentation, Hans-Dieter Zucht, Head of Technology at Protagen, spoke about the use of Luminex multiplexing technology for a workflow where the analytes are autoantibodies that target the host, and recombinant prote...

If you use ELISAs to test immunological responses, Siân Faustini from the University of Birmingham has this advice: “Serotype-specific assays are the way to go.” In her 20-minute webinar presentation from xMAP® Connect 2017, “E...

Paul Rhyne, PhD Chief Scientific Officer Biologic Development Services In this 25-minute webinar, you’ll learn about: - The basics of multiplexing plus considerations for the use of planar versus suspension (bead based) a...

James Lederer, PhD Associate Professor of Surgery Harvard Medical School In this 30-minute webinar, you’ll learn about: - Why single-mediator assays are obsolete and how multiplexing is aligned with current scientific cli...

Mariano Severgnini Lead Scientist at the Immune Assessment Lab in the Center for Immuno-Oncology Dana-Farber Cancer Institute In this 30 minute webinar, you'll learn about: - Verifying data across different technologies ...

Mahmoud Elsabahy is working to establish a new immunotoxicity index for multiplex data analysis and interpretation. He uses xMAP® Technology to trace the biomarker response to nanomedicines and nanocarriers. Dr. Elsabahy is the...